Transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles Immunization Program

Starting mid-October 2020, the Ontario publicly funded shingles (Herpes Zoster) immunization program will begin to transition to Shingrix® vaccine instead of Zostavax®II vaccine. It is important to note that this is for adults between 65-70 years of age. More information is available here: OPDP SHINGRIX funded Oct 2020